Please assess the completion status of the following clinical trial:

Trial Title: Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of mild asthma, currently well controlled requiring only a bronchodilator (e.g. salbutamol) as needed and infrequently~* has allergies that trigger asthma~* responds to methacholine challenge at 16mg/ml or less~* has FEV1 \> 69.5% predicted~Exclusion Criteria:~* respiratory illness within 4 weeks~* other medical condition assessed by the principal investigator that would put the participant at risk or influence the integrity of the data~* pregnant or lactating females~* hypersensitivity to ibuprofen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Ibuprofen (Type: EXPERIMENTAL): 400mg (2X200mg) ibuprofen single dose once
- Placebo (Type: PLACEBO_COMPARATOR): identical appearing lactose capsules single dose 2 capsules once

Based on this trial design, predict the completion outcome and termination type (if applicable).